abstract |
The present invention is based on the intestinal absorption of polyphenols comprising at least one polyethylene glycol (and / or functional equivalent (s)) and at least one glycol ether (and / or functional equivalent (s)). It relates to a formulation intended to improve bioavailability. The present invention is particularly well suited for improving the bioavailability of hydroxystilbenes, in particular 3,5,4'-trihydroxystilbene or resveratrol. |